Replay available

Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call

Treace Medical Concepts, Inc. (NASDAQ: TMCI) Q4 2025 earnings conference call, held 2026-02-27. Replay captured from the company's public earnings webcast.

Fri, February 27, 2026 at 8:00 AMendedReplay
Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Tripp Taylor

Investor Relations

John Treese

Chief Executive Officer

Mark Hare

Chief Financial Officer

Danielle Antalfi

Analyst, UBS

Lake Street Capital Markets Analyst

Analyst

Ryan Zimmerman

Analyst, BTIG

Rick Wise

Analyst, Stifel

Richard Newit

Analyst, Truist Securities

Lily Lozada

Analyst, JP Morgan

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Treece Medical Concepts fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded. After the speaker's presentation, there will be a question and answer session. To ask a question, please press star 1-1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1-1 again. I would now like to hand the conference over to your speaker today, Tripp Taylor, Investor Relations. Good morning, everyone, and welcome to our fourth quarter 2025. Company today will be John Treese, Chief Executive Officer, and Mark Hare, Chief Financial Officer. John and Mark will discuss our fourth quarter financial results in 2026 Outlook. We will then host a question and answer session following our prepared remarks. Our press release can be found in the investor relations section of our website at investors.treese.com. This call is being recorded and will be archived in the investor section of our website. Before we begin, we would like to remind you that it is our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. Any statements that relate to expectations or predictions of future events and market trends, as well as our estimated results or performance, are forward-looking statements. All forward-looking statements are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. All forward-lookin...

More from Treace Medical Concepts, Inc.